08 Oct 2025 | 5 Mins Read
CGHS rate revision benefits Max, Medanta, KIMS
Flipitmoney
The CGHS rates for 2,000 medical procedures in hospitals empanelled under the scheme, mainly benefiting private healthcare and hospital players. Rates will be 10-20% higher in tier-1 cities, and up to 22.2% higher for certain procedures. Brokerages predict a 2.5-3.5% increase in EBITDA, with Krishna Institute of Medical Sciences, Max Healthcare, and Medanta expected to gain.